BoNT/E Activity Detection via Cleaved SNAP-25 Antibody Assay
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the biological activity of Clostridial Neurotoxins, such as Botulinum toxin E, are often reliant on animal-based assays, which are costly, ethically challenging, and lack sensitivity, necessitating the development of alternative cell-based test systems that are more reliable and efficient.
Innovation Solution
A polyclonal or monoclonal antibody specifically binding to BoNT/E-cleaved SNAP-25 is developed, allowing for direct determination of BoNT/E biological activity in cells by quantifying the amount of SNAP-25 cleaved, using a method that involves incubating cells with BoNT/E, fixing and permeabilizing them, and then using capture and detection antibodies to form complexes that indicate the level of cleavage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If animal-based assays are used to determine BoNT/E biological activity, then the assay can detect biological activity, but the assay is costly, ethically challenging, and lacks sensitivity
Solution Approach 1:
The patent replaces animal-based biological assays with a cell-based immunodetection system using antibodies and ELISA technology. This substitution eliminates the need for live animals while providing higher sensitivity through specific antibody-antigen recognition and quantifiable detection methods.
Solution Approach 2:
The patent introduces specific antibodies as intermediaries between the BoNT/E toxin and the detection system. These antibodies bind specifically to cleaved SNAP-25, serving as a bridge that enables sensitive and specific detection of toxin activity without requiring complex animal-based assays.
2Reliability
If cell-based test systems are developed to replace animal assays, then ethical challenges are reduced and sensitivity is improved, but the method complexity increases
Solution Approach 1:
The patent divides the detection method into distinct sequential steps: cell incubation with toxin, fixation, permeabilization, capture antibody binding, detection antibody binding, and signal measurement. This segmentation makes the complex cell-based assay more manageable, reproducible, and easier to standardize across different laboratories.
Solution Approach 2:
The patent includes preliminary steps of cell fixation and permeabilization before antibody binding. These preliminary actions prepare the cells in a standardized state, ensuring consistent antibody access to intracellular antigens and improving assay reliability across different experiments.
3Productivity
If direct determination of BoNT/E activity in cells is performed, then labor and time are reduced, but the need for specific antibodies increases device complexity
Solution Approach 1:
The patent employs a universal detection platform (ELISA) that can detect different BoNT serotypes by simply changing the specific antibodies used. This multi-functional approach allows the same basic assay protocol to be applied across multiple toxin types, improving productivity while managing complexity through standardized procedures.
Solution Approach 2:
The patent uses parameter changes in the form of different antibody specificities to detect various BoNT serotypes. By changing only the antibody parameters while keeping the overall assay protocol constant, the system achieves high productivity across different toxin detections without proportionally increasing complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables precise and efficient measurement of BoNT/E activity within cells without the need for animal testing, reducing labor and time while providing a sensitive and reliable assay for biological activity, overcoming the limitations of existing methods.
Implementation Method 1
a polyclonal or monoclonal antibody specifically binding to BoNT/E-cleaved SNAP-25
Implementation Method 2
contacting the cells with at least a first capture antibody specifically binding to non-cleaved and BoNT/E-cleaved SNAP-25, and with at least a second capture antibody specifically binding to BoNT/E-cleaved SNAP-25, wherein the second capture antibody is an antibody of the invention, under conditions which allow for binding of said capture antibodies to the indicated substrates
Data Source
AI summary
The present invention pertains to a polyclonal or monoclonal antibody specifically binding to BoNT/E-cleaved SNAP-25. Further, the invention provides a method for directly determining the biological activity of BoNT/E in cells, comprising the steps of: a) incubating cells susceptible to BoNT/E intoxication with BoNT/E for a time and under conditions which allow for the BoNT/E to exert its biological activity; b) fixing the cells and, optionally, permeabilizing the cells with a detergent; c) contacting the cells with at least a first capture antibody specifically binding to non-cleaved and BoNT/E-cleaved SNAP-25, and with at least a second capture antibody specifically binding to BoNT/E-cleaved SNAP-25, wherein the second capture antibody is an antibody of the invention, under conditions which allow for binding of said capture antibodies to the indicated substrates; d) contacting the cells with at least a first detection antibody specifically binding to the first capture antibody, under conditions which allow for binding of said first detection antibody to said first capture antibody, thus forming first detection complexes, and with at least a second detection antibody specifically binding to the second capture antibody, under conditions which allow for binding of said second detection antibody to said second capture antibody, thus forming second detection complexes, and wherein the first detection antibody is different from the second detection antibody; e) determining the amount of the first and second detection complexes of step d); and f) calculating the amount of SNAP-25 cleaved by BoNT/E in said cells by means of the second detection complexes, thereby determining the biological activity of BoNT/E in said cells. Furthermore, the invention relates to a kit for carrying out the method of the invention.